KÜÇÜKGÖZ GÜLEÇ, Ü. Et Al. 2017. Programmed Death-1 (PD-1), Programmed Death Ligand 1(PD-L1) Expression in Type 2 Endometrial Cancer.. 20’th European Society of Gynecologic Oncology (ESGO) Congress .

KÜÇÜKGÖZ GÜLEÇ, Ü., KILIÇ BAĞIR, E., PAYDAŞ, S., SEYDAOĞLU, G., GÜMÜRDÜLÜ, D., GÜZEL, A. B., ... VARDAR, M. A.(2017). Programmed Death-1 (PD-1), Programmed Death Ligand 1(PD-L1) Expression in Type 2 Endometrial Cancer. . 20’th European Society of Gynecologic Oncology (ESGO) Congress

KÜÇÜKGÖZ GÜLEÇ, ÜMRAN Et Al. "Programmed Death-1 (PD-1), Programmed Death Ligand 1(PD-L1) Expression in Type 2 Endometrial Cancer.," 20’th European Society of Gynecologic Oncology (ESGO) Congress, 2017

KÜÇÜKGÖZ GÜLEÇ, ÜMRAN K. Et Al. "Programmed Death-1 (PD-1), Programmed Death Ligand 1(PD-L1) Expression in Type 2 Endometrial Cancer.." 20’th European Society of Gynecologic Oncology (ESGO) Congress , 2017

KÜÇÜKGÖZ GÜLEÇ, Ü. Et Al. (2017) . "Programmed Death-1 (PD-1), Programmed Death Ligand 1(PD-L1) Expression in Type 2 Endometrial Cancer.." 20’th European Society of Gynecologic Oncology (ESGO) Congress .

@conferencepaper{conferencepaper, author={ÜMRAN KÜÇÜKGÖZ GÜLEÇ Et Al. }, title={Programmed Death-1 (PD-1), Programmed Death Ligand 1(PD-L1) Expression in Type 2 Endometrial Cancer.}, congress name={20’th European Society of Gynecologic Oncology (ESGO) Congress}, city={}, country={}, year={2017}}